COMPANY PROFILE / #3400
BRAINBox Solutions
Richmond, VAVenture Capital-Backed
OVERVIEW
Developer of a medical technology platform designed to offer a multi-modality approach to the diagnosis and prognosis of mild traumatic brain injury. The company's platform offers blood biomarker panels for standard laboratory systems (including point of care) and neurocognitive testing, producing an artificial intelligence-driven score, enabling the healthcare sector to provide objective answers as to who will recover or have ongoing (and which) symptoms.
已融资38.00
最新估值42.09
员工数17
成立年份2018
公司概况
- Companies
- BRAINBox Solutions
- Description
- Developer of a medical technology platform designed to offer a multi-modality approach to the diagnosis and prognosis of mild traumatic brain injury. The company's platform offers blood biomarker panels for standard laboratory systems (including point of care) and neurocognitive testing, producing an artificial intelligence-driven score, enabling the healthcare sector to provide objective answers as to who will recover or have ongoing (and which) symptoms.
- Website
- www.brainboxinc.com
- HQ Location
- Richmond, VA
- Year Founded
- 2018
- Keywords
- brain injury detection, brain injury diagnostics, medical advice, medical technology, pathology device, technology platform, traumatic brain injury
- Competitors
- Ionpath, E25Bio, Meridian Bioscience, Oculogica, Cepheid, ChipCare, BrainScope, Oxford Nanopore Technologies, Agena Bioscience, Autogenomics, Ayoxxa Biosystems, ImPACT Applications, Akonni Biosystems, Illumina, Cerora, Cytek Biosciences, Adarza BioSystems, CNS Vital Signs, Veran Medical Technologies, Mindful Scientific, InfraScan, Banyan Biomarkers, T2 Biosystems, Preomics, Akoya Biosciences
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 38.00
- First Financing Date
- 16-Apr-2020
- First Financing Size
- 0.19
- First Financing Valuation
- —
- Last Financing Date
- 07-Nov-2023
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 10.00
- Last Financing Valuation
- 42.09
- Last Financing Status
- Completed
- Last Known Valuation
- 42.09
- Last Known Valuation Date
- 07-Nov-2023
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 46.87
- Valuation Estimate Growth Rate
- 11.37%
- Active Investors
- Ambit Health Ventures, Astia, BioVentures Investors, Blue Leaf Ventures, CAV Angels, Chainstay Capital, Genoa Ventures, Jenny Barba, Johns Hopkins Technology Ventures, Kevin Love, Laszlo N. Tauber Family Foundation, National Institutes of Health, National Institutes of Neurological Disorders and Stroke, Pharmakon Advisors, Virginia Innovation Partnership Corporation, Virginia Venture Partners, VTC Ventures
- # Active Investors
- 17
- Acquirers
- —
团队与联系人
- Employees
- 17
- Employee Growth %
- 70.00%
- Employee History
- 2026: 17, 2025: 10, 2024: 15, 2023: 15, 2022: 11, 2021: 11, 2020: 8, 2019: 10, 2018: 10
- Primary Contact
- Donna Edmonds
- Primary Contact Title
- Chief Executive Officer & Board Member
- Primary Contact Email
- dedmonds@brainboxinc.com
- Primary Contact Phone
- +1 (804) 212-2975
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.46%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 94
- Size Multiple
- 4.81x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 80
- Majestic Referring Domains
- 195
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3400 · 所有字段均按数据库原值展示。